| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Octreotide | FAERS: 2 | US FAERS | |
| 2 | Tacrolimus | FAERS: 2 | US FAERS | |
| 3 | Teriparatide | FAERS: 2 | US FAERS | |
| 4 | Cyclosporine | FAERS: 1 | US FAERS | |
| 5 | Doxorubicin | FAERS: 1 | US FAERS | |
| 6 | Everolimus | FAERS: 1 | US FAERS | |
| 7 | Fluorouracil | FAERS: 1 | OFFSIDES US FAERS | |
| 8 | Ibuprofen | FAERS: 1 | US FAERS | |
| 9 | Rivaroxaban | FAERS: 1 | US FAERS | |
| 10 | Sevoflurane | FAERS: 1 | US FAERS | |
| 11 | liposomal doxorubicin | FAERS: 1 | US FAERS | |
| 12 | reviparin | FAERS: 1 | US FAERS | |
| 13 | Ganciclovir | OFFSIDES | ||
| 14 | Octreotide | Canada Vigilance: 1 | Canada Vigilance | |
| 15 | Piperacillin, Tazobactam Drug Combination | OFFSIDES | ||
| 16 | Prazosin | OFFSIDES | ||
| 17 | Tropisetron | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.